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According to the European Resuscitation Council guidelines, the use of mechanical chest compression devices is a reasonable
alternative in situations where manual chest compression is impractical or compromises provider safety. The aim of this study is to
compare the performance of a recently developed chest compression device (Corpuls CPR) with an established system (LUCAS II)
in a pig model.Methods. Pigs (𝑛 = 5/group) in provoked ventricular fibrillation were left untreated for 5 minutes, after which 15min
of cardiopulmonary resuscitation was performedwith chest compressions. After 15min, defibrillation was performed every 2min if
necessary, and up to 3 doses of adrenaline were given. If there was no return of spontaneous circulation after 25min, the experiment
was terminated. Coronary perfusion pressure, carotid blood flow, end-expiratory CO
2
, regional oxygen saturation by near infrared
spectroscopy, blood gas, and local organ perfusion with fluorescent labelled microspheres were measured at baseline and during
resuscitation. Results. Animals treated with Corpuls CPR had significantly higher mean arterial pressures during resuscitation,
along with a detectable trend of greater carotid blood flow and organ perfusion. Conclusion. Chest compressions with the Corpuls
CPR device generated significantly higher mean arterial pressures than compressions performed with the LUCAS II device.
1. Introduction
Chest compressions are crucial for maintaining coronary and
cerebral perfusion during cardiac arrest. The efficiency of
manual chest compressions during cardiopulmonary resus-
citation (CPR) decreases over time [1, 2], and it is difficult
to perform efficient chest compressions during transporta-
tion or during interventional procedures, for example, in a
catheter lab.
In order to address these problems, a variety of devices
that perform mechanical chest compressions have been
developed and tested in animal experiments, experimental
investigations using manikins, and clinical studies [3–7].
The 2015 European Resuscitation Council (ERC) guide-
lines for CPR recommend mechanical chest compression
devices as a reasonable alternative in situations where deliv-
ery of high performance chest compressions is impeded or
would compromise provider safety [8].
These devices should offer maximal flexibility for adap-
tation to the individual constitution of the patient, as well
as adequate battery capacity, low weight, and mechanical
stability that allows compressions of sufficient depth even at
high chest stiffness values. The LUCAS II device is currently
one of the most widely used chest compression machines
in clinical practice. This device has a closed frame that
surrounds the patient to provide a maximum of stability.
Corpuls CPR (GS ElektromedizinischeGera¨te G. Stemple
GmbH, Kaufering, Germany) is a newly introduced electric
device for chest compressions. Compression is generated by a
single, flexible, adaptable arm that is locked in a spine board
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or to a small baseplate positioned under the patient. The
device works with a duty cycle of 50% and typically has an
average battery capacity of 90min. It offers an adjustable
compression frequency from 80 to 120 compressions/minute
and a compression depth of 20–60mm. The therapy mode
can be changed between 30 : 2/15 : 2 and continuous mode.
The position of the stamp is checked after each ventilation
break or 100 compressions (continuous mode) and compen-
sated if a sunken thorax is detected [9–11].
The aim of the present study is to compare the effects of
the performance of this device with the clinically established
LUCAS II device in a pig model of cardiac arrest.
2. Materials and Methods
A total of 10 female German Landrace pigs weighing 25 ±
2.5 kg were used in the study. All animals received care in
compliance with the European convention for the protection
of vertebrate animals used for experimental and other scien-
tific purposes. The study protocol was approved by the local
government (Regierung von Oberbayern, Ref. number 55.2-
1-54-2532-205-2013).
Ketamine (15mg/kg), azaperone (2mg/kg), and atropine
(0.02mg/kg) were injected intramuscularly (neck region
according to Swindle and Smith [12]) for premedication.
The pigs were placed in a supine position, and endotracheal
intubation via tracheotomy was performed after intravenous
bolus injection of propofol (10mg/kg) and fentanyl (0.04mg).
Anesthesia was maintained by continuous infusion of propo-
fol (8mg/kg/h) and fentanyl (25 𝜇g/kg/h), and intravenous
Ringer’s solution (10–15ml/kg/h) was administered to main-
tain a mean arterial pressure of 80–90mmHg.
Volume-controlled ventilation (tidal volume 8 to
10ml/kg, PEEP 5 cmH
2
O, FIO
2
0.21 to 0.3, and𝑃max 45mbar)
was performed using an Evita II respirator (Draeger, Lu¨beck,
Germany). Oxygen was added to maintain saturation >95%.
End-expiratory CO
2
(mainstream technique) and oxygen
saturation (sensor placed at the tongue) as well as the
electrocardiogram (ECG) based on pads (Ambu Blue Sensor,
Ambu Germany, Friedheim) were monitored by a Corpuls 3
device (GS Elektromedizinische Gera¨te G. Stemple GmbH,
Kaufering, Germany). Respiratory frequency was adjusted
to maintain an end-expiratory CO
2
partial pressure between
35 and 40mmHg before cardiac arrest. Arterial blood gas
samples were taken from the introducer placed in the femoral
artery every 15min during preparation, and the ventilation
was adjusted accordingly.
An ultrasonic flow probe (Transonic 202, Ithaca, USA)
was placed around the right carotid artery, and a temporary
pacemaker wire was inserted into the right ventricle via
the right external jugular vein. Additionally, a catheter for
sampling aortic blood was placed via the subclavian artery.
Micromanometers (Millar-TIP SPC 350, Houston, TX, USA)
were placed in the ascending aorta and the right atrium
via bilateral femoral cutdown, and a pigtail catheter was
placed in the descending aorta from the left femoral arteria.
Blood pressure was monitored at the femoral artery with a
fluid-filled line and pressure transducer (Xtrans, PVB Codan
Critical Care, Forstinning, Germany).
Near infrared spectroscopy (NIRS) sensors (Equanox,
Nonin, North Plymouth, MN, USA) were placed in the
frontal region of the scull, in submental position, and on the
lower left quadrant of the abdomen for monitoring regional
oxygen saturation (% RO
2
) in accordance with the protocol
for humans weighing <40 kg (NO80004CB). Each area was
shaved and cleaned thoroughly with isopropanol prior to
placement of the sensors.
Hemodynamic data were recorded continuously at a
frequency of 1 kHz with Powerlab 8.0 (AD Instruments,
Oxford, UK).
Fluorescent labelled microspheres (Molecular Probes,
15 𝜇m, Life Technologies, Eugene, OR, USA) were used to
measure local organ perfusion at baseline and after 5min of
resuscitation as follows: 106 microspheres/10 kg body weight
were injected via the pigtail catheter, whichwas directly above
the aortic valve, and reference samples were taken via syringe
pump over a catheter placed in the descending aorta at a rate
of 10mL/min for 4 minutes.
Before initiation of ventricular fibrillation, the pigs were
randomised into two groups, Corpuls CPR (CCPR) or
LUCAS II CPR, by a sealed envelope method. Pigs that
received CCPR were secured to a v-shaped board prior
to induction of ventricular fibrillation and those that were
treated with the LUCAS II device were secured inside the
device by padding on the left and right sides between the pig
and the load frame (Figure 1).
Resuscitation was performed according to the protocol
outlined in Figure 1. Ventricular fibrillation was induced by
a 14V direct current pulse via the pacemaker and the pigs
were left untreated for 5min.The respirator was disconnected
and the infusion of propofol and fentanyl was stopped. After
5min, CPR was initiated. Both devices were operating with
100 compressions/min in continuous mode and a compres-
sion depth of 50mmwith a duty cycle 50%. 10 ventilations per
minute were performedwith a Ruben bag supplied with 100%
oxygen.
The fluorescent microspheres were injected at 5min of
resuscitation. After 15min of continuous resuscitation the
compressions were stopped and defibrillation was performed
with a 150 J biphasic impulse in cases of ongoing ventricular
fibrillation. Compressions were then resumed for 2min, and
up to 3 doses of epinephrine (0.01mg/kgmg) were given after
3 cycles of 2min chest compression after defibrillation. If
there was no return of spontaneous circulation (ROSC) after
6 times of defibrillation and 3 doses of epinephrine the exper-
iment was stopped. Necropsies were performed with special
attention to compression-related chest injuries that might
have affected ROSC (pericardial effusion, pneumothorax,
hemothorax).
Blood gas samples were collected every 5min after
initiation of cardiac arrest; the sampling included lactate
measurement by Siemens Rapid Point 500 (Siemens, Erlan-
gen, Germany). Cardiac perfusion pressure was calculated
according to the end diastolic method [13] using an average
of 10 compression cycles. Mean arterial pressure (MAP),
mean carotid blood flow (CBF), regional oxygen saturation
(% RO
2
) by NIRS, and end-expiratory CO
2
(ETCO
2
) were
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Figure 1: (a) Pig in a v-shaped board during treatment with the Corpuls CPR. (b) Pig fixed with cushions in the LUCAS II. (c) Description
of the study protocol, MS: microsphere injection, BG: blood gas sample, D: defibrillation, A: administration of adrenaline.
also measured to evaluate the performance of the resusci-
tation devices. The data was recorded continuously using
Powerlab and Labchart (AD Instruments, Sydney, Australia).
For evaluation, baseline data before initiation of ventricular
fibrillation, after 5 minutes of cardiac arrest, and during
resuscitation (1; 5; 10; 15; 20 minutes) were taken.
Normal distribution of the data was analyzed using the
Kolmogorov–Smirnov test. Comparison of variables between
the 2 groups was performed with Student’s 𝑡-test for unpaired
observations. A 𝑝 value of <0.05 was regarded as an indicator
of statistically significant differences between the groups. All
statistical analyses were carried out using IBM SPSS V20.
3. Results
MAPmeasured at the femoral artery was significantly higher
during CCPR throughout resuscitation period (MAP =
approximately 43mmHg, CCPR, versus 23mmHG, LUCAS
II).
CBF declined to 30% of the baseline value at the begin-
ning of resuscitation and decreased to 20% of the initial value
at the end of the resuscitation period. CBF was significantly
higher in the CCPR group after 20min of resuscitation
and after administration of vasopressors. Detailed results are
shown in Table 2 and Figure 3.
There were no significant differences between the groups
in baseline ETCO
2
, MAP, CPP, CBF, % RO
2
, lactate levels,
or degree of local organ perfusion by microspheres. Detailed
results are presented in Table 1.
CPP during resuscitationwas similar between the groups,
measuring approximately 20mmHg for both.
There was also no significant difference between groups
in the degree of local organ perfusion by microspheres after
5min of resuscitation. Cerebral perfusion levels of 23 ± 7.5%
of baseline were recorded for the CCPR group, compared
to 12.6 ± 6.7% of baseline in the LUCAS II group. Cardiac
perfusion of 26 ± 9% of baseline was detected in the CCPR
group, compared to a cardiac perfusion of 17±2% of baseline
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Table 1: Baseline values in the two groups showed no statistical difference.
MAP
[mmHg]
CPP
[mmHg]
Av. CBF
[ml/min]
ET CO
2
[mmHg] PH
Lac
[mmol/L]
CCPR 79 ± 2.6 56.8 ± 4.7 82 ± 23 37.9 ± 3.1 7,4 ± 0.02 1.5 ± 0,38
LUCAS II 82 ± 12.1 57.2 ± 13.1 79.6 ± 15.4 37.2 ± 0.75 7.4 ± 0.04 1.59 ± 0.34
Local perfusion Brain
[ml/min 100 g]
Heart
[ml/min 100 g]
Kidney
[ml/min 100 g]
Liver
[ml/min 100 g]
CCPR 36.6 ± 5.08 93.8 ± 18.68 236 ± 38.2 28.6 ± 8.55
LUCAS II 36 ± 3.63 110.4 ± 6.53 230.6 ± 48.2 25 ± 3.3
MAP: mean arterial pressure; CPP: cerebral perfusion pressure; Av. CBF: average cerebral blood flow; ET CO2: end-tidal carbon dioxide; Lac: lactate; CCPR:
Corpuls CPR.
Table 2: Mean arterial pressure, local perfusion, Et CO
2
, and carotid blood flow during resuscitation.
MAP
[mmHg]
MAP
1 minute
MAP
5 minutes
MAP
10 minutes
MAP
15 minutes
MAP
20 minutes
CCPR 49.4 ± 7.58 42.2 ± 7.11 45.6 ± 13.7 43.4 ± 9.2 43.2 ± 10.7
LUCAS II 25.9 ± 6.53 25,54 ± 6.53 23.0 ± 6.7 21.6 ± 6.4 21.9 ± 6.6
CBF
[ml/min]
CBF
1 minute
CBF
5 minutes
CBF
10 minutes
CBF
15 minutes
CBF
20 minutes
CCPR 26.6 ± 8.45 26.4 ± 5.68 24.0 ± 3.85 18.8 ± 4.7 18.2 ± 4.8
LUCAS II 20.82 ± 8.01 18.9 ± 9.34 15.5 ± 8.43 11.66 ± 5.21 6.48 ± 3.23
Et CO
2
[mmHg]
Et CO
2
1 minute
Et CO
2
5 minutes
Et CO
2
10 minutes
Et CO
2
15 minutes
Et CO
2
20 minutes
CCPR 22.62 ± 9.27 34.6 ± 25.76 23.1 ± 12.64 17.68 ± 7.08 15.94 ± 8.42
LUCAS II 22.58 ± 5.49 22.88 ± 9.31 22.84 ± 10.5 19.88 ± 9.96 15.9 ± 4.17
Local perfusion at 5min Brain
[ml/min 100 g]
Heart
[ml/min 100 g]
Kidney
[ml/min 100 g]
Liver
[ml/min 100 g]
CCPR 8.24 ± 2.17 25 ± 8.39 45.8 ± 18.5 3.4 ± 2.06
LUCAS II 4.54 ± 2.41 18.8 ± 1.94 46.6 ± 11.3 2.24 ± 0.73
MAP:mean arterial pressure.Mean arterial pressure was significantly higher in the Corpuls CPR group throughout the entire resuscitation period. CBF: carotid
blood flow. Carotid blood flow was significantly higher in the Corpuls CPR group at 20min. CCPR: Corpuls CPR.
in the LUCAS II group. Renal perfusion decreased to 19.4 ±
7.8% of baseline in the CCPR group and to 20.2 ± 4.9%
of baseline in the LUCAS II group. Hepatic perfusion also
declined to 12.1 ± 7.3% of baseline in the CCPR group and
8.9 ± 2.9% in the LUCAS II group.
NIRS measurements did not differ significantly between
the groups. Measurements taken with the submental sensor
indicated a decrease in oxygen saturation of about 20%
from baseline after 5min of cardiac arrest. Regional oxygen
saturation increased by approximately 10% during CPR.
Measurements obtained by probes in the frontal position
showed a decrease in oxygen saturation to approximately
65% of baseline at 5min after cardiac arrest and this value
increased to approximately 70% of baseline during CPR.
The peripheral sensors indicated regional oxygen saturation
of approximately 80% of baseline at 5min after arrest; this
increased to 90% of baseline during CPR. There were no
significant differences in % RO
2
between groups at any of the
sensor positions. Detailed results are shown in Figure 2.
Finally, there were no significant differences in ETCO
2
,
potassium levels, lactate levels, or pH values between the two
groups. There was a slight increase of CO
2
detected after
5min of resuscitation,which decreased again (Table 2) during
resuscitation. pH values were decreased in both groups
from a baseline of approximately 7.4 to 7.25 after 20min of
resuscitation. Potassium levels increased during treatment,
from approximately 4.2mmol/L at baseline to 6.8mmol/L
at the end of the experiment. The lactate levels increased
from approximately 1.55mmol/L at baseline to 8.2mmol/L
at the end of the experiment (Table 3). Three animals from
each group received defibrillation; 2 animals per group were
asystolic after 15min of CPR; and no pig in either group
had ROSC. At autopsy, in the macroscopic inspection of the
opened chestwe detected no rib fractures that caused harmful
injuries influencing ROSC like pneumothorax, hemothorax,
or pericardial effusions in either group.
4. Discussion
The haemodynamic parameters at baseline and during resus-
citation in our experiments corresponded to the results of
previous evaluations of mechanical resuscitation devices.
Halperin et al. [6] generated CPP between 14 and 21mmHg,
cerebral flow of approximately 0.2mL/min/g, and MAP of
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Figure 2: Coronary perfusion pressure and regional oxygen saturation (frontal region, submental placement, periphery placement) during
resuscitation. No significant difference was detectable over the whole period (𝑝 > 0.05). Submental placement seems to produce the highest
changes in % RO
2
between the different measurement points in our pig model.
approximately 36mmHg during CPR using a load distribut-
ing band (Autopulse). Steen et al. [7], in an evaluation of
a LUCAS device, measured CBF of approximately 30% of
baseline andMAPof approximately 40mmHg, and Liao et al.
[14] reported CPP of >20mmHg and a CBF of approximately
30 to 35%of baseline duringCPRwith the LUCAS II device in
pigmodels.TheLUCAS II system is presently themost widely
used mechanical chest compression system, and a number
of experiments and clinical trials have been performed to
evaluate its efficacy [15–20]. Therefore, we used the LUCAS
II system as the reference device for comparison with the
Corpuls CPR device.
We found that the Corpuls device was able to generate
a significantly higher MAP than the LUCAS device. There
was also a trend towards greater CBF and improved local
organ perfusion with the Corpuls device, although this was
not statistically significant.
The ability of CCPR to generate higher MAP and CBF
might be related to a difference in the compression waveform
[9] or to the different shape of the chest compression plate.
Neither of the compression plates that were used in our
experiments has a feature for active chest recoil, and the
diameters of the contact areas are comparable. Thus, the
difference in flow and pressure is probably not related to the
compression plate.
On the other hand, CCPR produces a slightly more trape-
zoidal compression waveform than the LUCAS II device.
Using an artificial chest model with integrated blood flow we
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Figure 3: Mean arterial pressure and carotid blood flow during resuscitation (∗𝑝 < 0.05). Corpuls CPR is generating a significantly higher
mean arterial pressure during the whole resuscitation period. Carotid blood flow seems to be higher by trend during the resuscitation period;
after 20 minutes of resuscitation a significant difference could be detected.
Table 3: Blood gas values at baseline and during resuscitation (mean and SD).
pH value Baseline 1minresuscitation
5min
resuscitation
10min
resuscitation
15min
resuscitation
20min
resuscitation
CCPR 7.41 ± 0.02 7.44 ± 0.1 7.37 ± 0.07 7.23 ± 0.12 7.19 ± 0.21 7.25 ± 0.16
LUCAS II 7.42 ± 0.04 6.86 ± 1.18 7.39 ± 0.14 7.35 ± 0.1 7.34 ± 0.11 7.31 ± 0.08
Potassium
[mmol/l] Baseline
1min
resuscitation
5min
resuscitation
10min
resuscitation
15min
resuscitation
20min
resuscitation
CCPR 4.2 ± 0.28 5.02 ± 0.95 6.39 ± 0.34 6.06 ± 0.39 6.15 ± 0.38 6.76 ± 0.85
LUCAS II 4.11 ± 0.24 4.77 ± 0.49 6.72 ± 0.54 6.34 ± 0.83 6.21 ± 0.8 6.81 ± 0.75
Lactate
[mmol/l] Baseline
1min
resuscitation
5min
resuscitation
10min
resuscitation
15min
resuscitation
20min
resuscitation
CCPR 1.52 ± 0.38 2.91 ± 1.97 5.68 ± 2.41 6.87 ± 1.88 7.65 ± 1.48 8.69 ± 1.76
LUCAS II 1.59 ± 0.34 2.1 ± 0.35 5.35 ± 1.44 6.27 ± 1.3 6.6 ± 1.19 8.1 ± 1.35
could measure the compression waveform of the two devices
and produce analogue results concerning MAP and arterial
blood flow comparing the LUCAS II and the Corpuls CPR
[9]. Kramer-Johansen et al. [1] have reported similar results
secondary to modifications of the compression waveform in
a computer simulation as well as in a pig model. There are
two effects that are mentioned in literature causing blood
circulation during CPR, the direct cardiac compression and
the thoracic pump theory [21, 22]. If the flow is predominantly
created by the thoracic pump, a more trapezoid compression
waveform with prolonged compression time will increase the
flow. In the chest of a pig the ventricles are embedded with
lung tissue from all sides, and the compressions given to
the thorax are affecting the heart and the big vessels much
more by the thoracic pump mechanism than by the direct
compression mechanism in humans [14]. This might also be
an explanation that although having similar cardiac perfusion
pressures in the group of Corpuls CPR, a higher MAP could
be generated.
In a study performed by Paradis et al. [23] only patients
with a CPP of 15mmHg or higher reached ROSC. Similar
findings for pigs were obtained by Steen et al. [7]. In our
study, CPP values of >15mmHg were reached in all animals
during CPR, and there were no signs of pericardial effusion
or pneumothorax at necropsy that would have been affecting
ROSC. However, none of the animals had ROSC. In a pig
model with a comparable study design Liao et al. reached a
ROSC rate of 100% using the LUCAS II device [14]. Unlike
our examination, they used a suction cup that provides active
chest recoil. Consecutively this resulted in significantly lower
pressure in the right atrium during the decompression phase
and additionally in a higher intrathoracic aortic pressure
during the end decompression phase. We used the german
model of LUCAS II with holes in the suction cup, which
allows no active chest recoil in the decompression phase.
Another difference from the examination of Liao et al. is
the animals they used in their study. In contrast to us, they
used Swedish domestic pigs with a mean weight of 31 kg; we
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were using German Landrace pigs with a mean weight of
25 kg. There could be an influence caused by the breed or
more probably due to the lower weight of the animals. In
contrast to their study, we also had found pigs having asystole
after 15 minutes of CPR in both groups. Also the vasocon-
strictive effect of the administered adrenaline could not be
detected significantly. These two additional findings can also
be related to the compression without active chest recoil, or
breed and weight.
Our protocol was designed to characterize the differences
in flow and pressure related to the chest compression device,
with minimized influence of defibrillation or drugs. That is
why we chose to allow a long interval of ventricular fibril-
lation (5min), compared to prior investigations in which the
untreated interval was only 60 to 90 s [6, 7, 24].With this con-
sideration, we accepted a lower chance of ROSC in exchange
for study conditions that favoured evaluation of the influence
of different compression devices on haemodynamic perfor-
mance.
Additionally, in our protocol, the first 15min of resuscita-
tion included onlymechanical chest compressions andRuben
bag ventilation. No additional treatments, that is, defibril-
lation or medications, were provided during this period. It
has been shown that survival rates and neurological outcome
are worse after a longer duration of fibrillation in men and
in pig [25–28], and early defibrillation and administration of
antiarrhythmic drugs or vasopressors would have most likely
increased the rate of ROSC in our study.
Peak forces of up to 600N have been reported during
chest compression [29–31]. The frame of a resuscitation
device must be very rigid to reach a compression depth of
50mm. Examination of the recorded data of the LUCAS II
device used in 59 cases of cardiac arrest by Beesems et al.
[32] showed that the LUCAS II device was able to generate
sufficient compression of 50mm in all cases.
There was initial concern that the flexible open frame of
the Corpuls CPR device would not have sufficient rigidity to
ensure proper compression depths in different chest profiles.
In previous experiments based on a mechanical chest model
[9] and in the animal experiments, there were no difficulties
reaching the recommended compression depth of 50mm
with the Corpuls device in any case, and no immoderate
bending or moving of the stamp on the compression area was
noted.
Several studies have been performed to determine the
usefulness of NIRS as a neuromonitoring tool for prediction
of outcomes, detection of ROSC, or evaluation of the quality
of brain perfusion during CPR [33]. We found a significant
difference in % RO
2
between baseline, after 5min of cardiac
arrest, and after 5min of CPR.We also found a very high level
of interindividual deviation of the absolute values of % RO
2
,
which might indicate that the chosen sensor system that was
designed for the human brain is not suitable for examination
in pigs.
We were using the smallest available paediatric sensors
for NIRSmonitoring, which are designed for human use.The
dimensions of the skull and brain of the pig are anatomically
different from those of the human, and this might explain
the large interindividual spread of the recorded values. In
our opinion, in experiments with a pig model, submental
sensor placement is preferable to frontal region placement
for monitoring cerebral perfusion. We found that the most
impressive changes with the least interindividual deviation
were detected when the sensors were placed in the submental
position.This might be due to better adaptation of the sensor
to the tissue in the submental region, as the plane area for
correct sensor placement in the frontal region is limited.
Wewere able to useNIRS tomeasure baseline oxygen sat-
uration values before cardiac arrest. The usefulness of infor-
mation obtained fromNIRS measurements during resuscita-
tion might be limited without prior baseline measurements,
as is often the case in real world emergency situations.
Nonetheless, our results support the conceptual premise that
regional oxygen saturation can detect changes in cerebral per-
fusion brain during CPR. Whether this method is suitable to
predict ROSC or the neurological outcome, as other authors
have suggested [34, 35], or whether it can provide further
information regarding the quality of CPR cannot be finally
answered based on the design and results of our study. Fur-
ther investigations focusing especially on the use of NIRS in
CPR are necessary.
5. Conclusion
In conclusion, we found that the Corpuls CPR device was
equivalent or superior to the LUCAS II system in terms
of blood pressure and flow during resuscitation in a pig
model of cardiac arrest. Chest compressions with the Corpuls
CPR device generated significantly higher MAP compared to
compressions with a LUCAS II device.
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